Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
The country had the third-largest number of people living with disease.
The tycoon had been allowed to use an office, phone, internet connection and three secretaries.
Godrej and some other firms are frustrated at what they say is the slow execution of projects and lack of government support, which are hampering India's efforts to compete with China and Russia as a cheaper option for launching satellites.
Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.
India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country's drug pricing authority told Reuters on Friday.
India had the third-largest number of people living with HIV in the world at the end of 2013 and accounts for about four out of 10 people living with HIV in the Asian region.
Hindi news channel News Nation TV showed laboratories in the national capital offering commissions as high as 50 per cent to doctors who referred patients to their diagnostic centres.
The comments came after Indian Finance Minister Arun Jaitley warned of tough measures in his first budget on July 10, saying 'mindless populism' needs to be checked as India aims to boost growth.
The health ministry has formed a committee to consider raising the number of drugs deemed essential and subject to price caps.
Both companies can now complete the deal.
Twitter is planning to replicate parts of its India election strategy across countries that go to polls this year, after it emerged as a key tool for politicians and media companies during the world's largest democratic exercise.
Two individuals filed the petition in the high court of Andhra Pradesh
There are just 1,500 drug inspectors responsible for more than 10,000 factories in India
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
The performance is affected as bets on small- and mid-cap shares went wrong.